Expression of CD44 and SALL4 in leukoplakia and oral squamous cell carcinoma

被引：0

作者：

Sahoo, Pravudeva ^{[1
]}

Kumar, Harish ^{[2
]}

Panda, Abikshyeet ^{[2
]}

Dash, Kailash Chandra ^{[2
]}

Bhuyian, Lipsa ^{[2
]}

Raghuvanshi, Malvika ^{[2
]}

Panda, Baisali ^{[2
]}

机构：

[1] Bhubaneswar ENT & Dent Care, Bhubaneswar, Odisha, India

[2] Kalinga Inst Dent Sci, Dept Oral & Maxillofacial Pathol, Campus 5, Bhubaneswar 751024, Odisha, India

来源：

JOURNAL OF PHARMACY AND BIOALLIED SCIENCES | 2024年 / 16卷

关键词：

CD44; leukoplakia; oral cancer; SALL4;

D O I：

10.4103/jpbs.jpbs_1178_23

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

CD44 and SALL4 are markers of stemness and expressed in cancer stem cells (CSCs). Their deregulated expression was seen in various tumors and has been correlated with clinical severity. We evaluated immunohistochemical expression of CD44 and SALL4 in leukoplakia and oral squamous cell carcinoma (OSCC). CD44 was expressed in all the cases of leukoplakia and Its expression correlated with severity of the dysplasia in leukoplakia but varied with differentiation in OSCC. SALL4 did not express in leukoplakia. Its expression was varied in OSCC cases. We opine that CD44 expression is consistent with the progression of dysplasia in leukoplakia and differentiation in OSCC.

引用

页码：1761 / 1763

页数：3

共 50 条

[21] Prognostic value of CD44 expression in invasive squamous cell carcinoma of the vulva
Rodríguez-Rodríguez, L
Sancho-Torres, I
Watelet, LM
Gibbon, DG
Comerci, JT
Mesonero, C
GYNECOLOGIC ONCOLOGY, 1999, 75 (01) : 34 - 40
[22] Hyaluronidase and CD44 hyaluronan receptor expression in squamous cell laryngeal carcinoma
Christopoulos, Th. A.
Papageorgakopoulou, N.
Theocharis, D. A.
Mastronikolis, N. S.
Papadas, Th. A.
Vynios, D. H.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2006, 1760 (07): : 1039 - 1045
[23] Expression of CD44 variant exons by primary and metastatic oral squamous carcinoma.
Oliveira, DT
Odell, EW
JOURNAL OF DENTAL RESEARCH, 1999, 78 (05) : 1018 - 1018
[24] CD44 expression in dysplastic epithelium and squamous-cell carcinoma of the esophagus
Roye, GD
Myers, RB
Brown, D
Poczatek, R
Beenken, SW
Grizzle, WE
INTERNATIONAL JOURNAL OF CANCER, 1996, 69 (04) : 254 - 258
[25] CD44 expression is related to poor prognosis of hypopharyngeal squamous cell carcinoma
Uwa, Nobuhiro
Kataoka, Tatsuki R.
Torii, Ikuko
Sato, Ayuko
Nishigami, Takashi
Song, Misa
Daimon, Takashi
Saeki, Nobuo
Sagawa, Kousuke
Mouri, Takeshi
Terada, Tomonori
Sakagami, Masafumi
Tsujimura, Tohru
ACTA OTO-LARYNGOLOGICA, 2011, 131 (03) : 323 - 329
[26] CD44 expression in sinonasal inverted papillomas and associated squamous cell carcinoma
Ingle, R
Jennings, TA
Goodman, ML
Pilch, BZ
Bergman, S
Ross, JS
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1998, 109 (03) : 309 - 314
[27] Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma.
Gotoda, T
Matsumura, Y
Kondo, TG
Ono, H
Kanamoto, A
Saito, D
Yamaguti, H
Nakanishi, Y
Kakizoe, T
GASTROENTEROLOGY, 2000, 118 (04) : A275 - A275
[28] Midkine expression in oral squamous cell carcinoma and leukoplakia
Jham, Bruno Correia
Costa, Nadia Lago
Silva, Janine Mayra
de Miranda, Alessandra Castro
Oliveira, Jose Carlos
Silva, Tarcilia Aparecida
Batista, Aline Carvalho
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2012, 41 (01) : 21 - 26
[29] 胃癌组织中SALL4、CD44的表达及其临床意义
傅冰洁
李付贵
俞霞
季明芳
何洁冰
标记免疫分析与临床, 2020, 27 (08) : 1345 - 1349
[30] The influence of CD44 splice variants to the outcome of patients with oral squamous cell carcinoma
Stoll, C
Baretton, G
Soost, F
Löhrs, U
GENE THERAPY OF CANCER, 1998, 451 : 51 - 55

← 1 2 3 4 5 →